☆ 4.7 Review

Natural Products in Precision Oncology: Plant-Based Small Molecule Inhibitors of Protein Kinases for Cancer Chemoprevention

NUTRIENTS (2023)

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

A recent update on small-molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry-based proteomic analysis

Pey Yee Lee et al.

Summary: Kinases play important roles in regulating biological processes and are associated with cancer. Small-molecule kinase inhibitors have revolutionized cancer treatment, but their selectivity and effectiveness are still challenging. This review provides an overview of the role of kinases in carcinogenesis, the progress of approved small-molecule kinase inhibitors, and the application of mass spectrometry-based proteomics strategies in kinase inhibitor design. It also discusses the challenges and outlook of mass spectrometry-based proteomics techniques for kinase drug research.

FEBS JOURNAL (2023)

Add to Collection
Review Pharmacology & Pharmacy

Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update

Robert Roskoski Jr

Summary: Due to protein kinase dysregulation, it has become crucial to target this enzyme family in many diseases, especially cancer. There are 72 FDA-approved drugs that target different protein kinases, with three of them receiving approval in 2022. These drugs target various types of protein kinases, and the majority are used to treat neoplasms and inflammatory diseases. This review provides a summary of the physicochemical properties of these drugs, including lipophilic efficiency and ligand efficiency.

PHARMACOLOGICAL RESEARCH (2023)

Add to Collection
Article Pharmacology & Pharmacy

The active kinome: The modern view of how active protein kinase networks fit in biological research

Khaled Alganem et al.

Summary: Biological regulatory networks are complex and challenging to study. Functional proteomics assessments are necessary to understand the active state of regulatory processes. Protein kinase activity profiling platforms, in combination with computational modeling techniques, provide valuable insights into the active state of regulatory systems and potential drug targets.

CURRENT OPINION IN PHARMACOLOGY (2022)

Add to Collection
Review Chemistry, Medicinal

Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets

Zhangfeng Zhong et al.

Summary: Immunotherapy has great potential in cancer treatment, but there are challenges such as immunotoxicity, single-source antibodies, and single-targeting strategies. Natural compounds from herbal medicines have shown promise as lead compounds for cancer treatment. This study summarizes current medication for cancer immunotherapy and discusses the potential of herbal medicines as immune checkpoint inhibitors with broad immunomodulatory effects.

MEDICINAL RESEARCH REVIEWS (2022)

Add to Collection
Article Chemistry, Multidisciplinary

Natural product drug discovery in the artificial intelligence era

F. I. Saldivar-Gonzalez et al.

Summary: Natural products are considered privileged structures to interact with protein drug targets, sparking interest in developing NP-inspired medicines. The advancement of artificial intelligence has democratized the field of natural product drug discovery, with the introduction of natural language processing and machine learning algorithms enhancing molecular design and target selectivity.

CHEMICAL SCIENCE (2022)

Add to Collection
Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Add to Collection
Review Pharmacology & Pharmacy

Natural Products Modulate Cell Apoptosis: A Promising Way for the Treatment of Ulcerative Colitis

Chenhao Liu et al.

Summary: Ulcerative colitis is a chronic inflammatory bowel disease that has a significant impact on patients' quality of life and imposes heavy burdens on society and the economy. Inhibiting the apoptosis of intestinal epithelial cells has been shown to be critical in managing ulcerative colitis, and natural products have been found to have anti-apoptotic effects. This review summarizes the research on the molecular mechanisms of the anti-apoptotic effects of natural products on ulcerative colitis.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection
Review Pharmacology & Pharmacy

Alpinetin: A Review of Its Pharmacology and Pharmacokinetics

Ge Zhao et al.

Summary: This article examines the mechanisms of action and pharmacokinetics properties of alpinetin, a natural flavonoid with various pharmacological activities. It proposes strategies for the future development of alpinetin in drug development and highlights its potential for prospective clinical applications.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection
Article Oncology

Building a Foundation for Precision Onco-Nutrition: Docosahexaenoic Acid and Breast Cancer

Henry J. Thompson et al.

Summary: Precision onco-nutrition (PON) uses specific nutrients and dietary factors to enhance cancer treatment efficacy by targeting signaling pathways specific to each molecular subtype. Research shows that DHA has greater anticancer activity in breast cancer cell lines compared to EPA, and specific metabolites of DHA can inhibit the growth of different molecular subtypes through differential effects on signaling pathways. These findings support the idea of combining targeted treatment strategies with specific n-3 fatty acid metabolites for managing breast cancer.

CANCERS (2022)

Add to Collection
Article Multidisciplinary Sciences

The use of machine learning modeling, virtual screening, molecular docking, and molecular dynamics simulations to identify potential VEGFR2 kinase inhibitors

Abbas Salimi et al.

Summary: Through the screening pipeline using machine learning classification and similarity checks, two potential candidate drugs for anti-angiogenesis therapy with strong binding to the target and comparable inhibitory activity to existing drugs have been found.

SCIENTIFIC REPORTS (2022)

Add to Collection
Review Pharmacology & Pharmacy

Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations

Chang-Lin Wang et al.

Summary: This review provides a comprehensive overview of the pharmacology, pharmacokinetics, toxicity and targeting preparations of TBMS-1, a natural triterpenoid saponin found in traditional Chinese herbal medicine. TBMS-1 shows a remarkable inhibitory effect on tumors in various systems, but can cause adverse effects at high doses. The development of targeting preparations and combination therapy with other drugs may improve the efficacy of TBMS-1 and reduce its toxicity.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection
Review Cell Biology

Plant-derived natural products for drug discovery: current approaches and prospects

Noohi Nasim et al.

Summary: Nature provides a rich source of drugs that can be used in modern medicine, either individually or in combination. These drugs include small bio-molecules, plant-made biologics, and phytopharmaceutical drugs. The development of phytopharmaceutical medicines is based on the traditional medicine system and the concept of polypharmacology, where natural products can target multiple physiological processes. This article summarizes different approaches for phytopharmaceutical drug development and discusses progress in identifying drug targets using systems biology and computational tools. The article also reviews existing drug delivery methods and analytical techniques for plant material authentication and fingerprinting, as well as the role of biopharming in developing plant-based biologics.

NUCLEUS-INDIA (2022)

Add to Collection
Review Chemistry, Medicinal

Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades

Mohd. Imran et al.

Summary: Protein kinase inhibitors are important therapeutic agents primarily used for treating cancer and inflammatory diseases. With time, more PKIs are expected to enter the generic drug market, potentially reducing the financial toxicity associated with existing PKIs. Despite the significant number of PKIs approved by the USFDA, there remains a large number of unexplored PKs.

PHARMACEUTICALS (2021)

Add to Collection
Article Biology

PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy

Pottayil G. Sasikumar et al.

Summary: CA-170 is a small molecule inhibitor that activates T cells and exhibits anti-tumor efficacy in mouse models, advancing to human clinical trials for its potential as an anti-cancer drug.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection
Review Oncology

Chemoprotective and chemosensitizing effects of apigenin on cancer therapy

Zahra Nozhat et al.

Summary: The review focuses on the combinatorial strategies involving apigenin in cancer therapeutics, highlighting its potential to enhance anti-cancer effects, reduce side effects, overcome drug resistance, and protect healthy cells when combined with chemotherapy drugs.

CANCER CELL INTERNATIONAL (2021)

Add to Collection
Review Food Science & Technology

Fisetin: An anticancer perspective

Muhammad Imran et al.

Summary: Fisetin, a dietary agent found in fruits and vegetables, has shown promising anticancer activity by inhibiting cancer cell stages, preventing progression in cell cycle and growth, and inducing apoptosis. Fisetin also modulates the expressions of various proteins in cancer cell lines and suppresses several signaling pathways involved in cancer development.

FOOD SCIENCE & NUTRITION (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Targeting Non-Oncogene Addiction for Cancer Therapy

Hae Ryung Chang et al.

Summary: This review highlights the importance of DNA replication, DDR, DNA repair, and cell cycle regulation in targeted cancer therapies, with a focus on potential therapeutic targets such as TONSL. The utilization of synthetic lethality for developing novel inhibitors targeting non-oncogene addiction in cancer therapy is also discussed in depth.

BIOMOLECULES (2021)

Add to Collection
Article Multidisciplinary Sciences

Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1

Jang-June Park et al.

Summary: A mechanism of inhibiting programmed death-ligand 1 through small molecule-induced dimerization and internalization was reported, showing potential therapeutic implications in oncology and chronic viral infections.

NATURE COMMUNICATIONS (2021)

Add to Collection
Article Nutrition & Dietetics

Measuring Dietary Botanical Diversity as a Proxy for Phytochemical Exposure

Henry J. Thompson et al.

Summary: The study of pharmacognosy provides a taxonomy for botanical families with potential functions in human health. Dietary phytochemicals can affect gut microbial composition and function, which in turn influences host health through multiple mechanisms. The development of a botanical diversity index (BDI) allows for evaluating plant food consumption as a metric for quantifying exposure to phytochemicals and investigating their impact on gut microbial ecology and functionality.

NUTRIENTS (2021)

Add to Collection
Review Pharmacology & Pharmacy

Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers

Fei Xu et al.

Summary: Icariside II, an active flavonoid extracted from Epimedii, possesses multiple biological and pharmacological properties, including anti-inflammatory, anticancer, and anti-osteoporotic effects. It has been shown to induce apoptosis, inhibit proliferation, cell cycle arrest, trigger autophagy, reduce cellular metabolism, and inhibit cancer metastasis and angiogenesis in various cancers. Additionally, it has a synergistic effect with chemotherapeutic drugs, although strategies to improve its therapeutic effects are being developed due to its poor solubility and permeability.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Review Medicine, Research & Experimental

Morin hydrate: A comprehensive review on novel natural dietary bioactive compound with versatile biological and pharmacological potential

Shahid Ali Rajput et al.

Summary: Morin hydrate, a bioflavonoid compound, demonstrates beneficial effects against various chronic and life-threatening degenerative diseases by exerting free radical scavenging, antioxidant, anti-inflammatory, anti-cancerous, anti-microbial, antidiabetic, anti-arthritis, cardioprotective, neuroprotective, nephroprotective, and hepatoprotective effects. It modulates cellular signaling pathways and biological networks, showing potential as a dietary agent for human health and future drug development, pending further human clinical trials to confirm its effects and safety profile.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells

Subashani Maniam et al.

Summary: Targeted chemotherapy has become the forefront of cancer treatment, offering more effective treatment with reduced side effects through selective and specific features; Research targeting the compensatory mechanisms in tumor cells is progressing in order to overcome drug resistance; Promising small molecules that target autophagy and apoptosis are being developed for the difficult-to-treat TNBC, showing potential in preclinical data.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection
Review Biotechnology & Applied Microbiology

Synthetic lethality as an engine for cancer drug target discovery

Alan Huang et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Add to Collection
Review Oncology

Personalized early detection and prevention of breast cancer: ENVISION consensus statement

Nora Pashayan et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Add to Collection
Review Pharmacology & Pharmacy

Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials

Cangcang Xu et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection
Review Biochemistry & Molecular Biology

Compounds from Natural Sources as Protein Kinase Inhibitors

Andrea Baier et al.

BIOMOLECULES (2020)

Add to Collection
Review Oncology

A compendium of mutational cancer driver genes

Francisco Martinez-Jimenez et al.

NATURE REVIEWS CANCER (2020)

Add to Collection
Review Pharmacology & Pharmacy

Properties of FDA-approved small molecule protein kinase inhibitors

Robert Roskoski

PHARMACOLOGICAL RESEARCH (2019)

Add to Collection
Article Medicine, General & Internal

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection
Review Nutrition & Dietetics

Precision Nutrition and the Microbiome, Part I: Current State of the Science

Susan Mills et al.

NUTRIENTS (2019)

Add to Collection
Article Biochemistry & Molecular Biology

The antitumor effect of hinesol, extract from Atractylodes lancea (Thunb.) DC. by proliferation, inhibition, and apoptosis induction via MEK/ERK and NF-κB pathway in non-small cell lung cancer cell lines A549 and NCI-H1299

Weigiang Guo et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Add to Collection
Review Nutrition & Dietetics

Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation

Susan Mills et al.

NUTRIENTS (2019)

Add to Collection
Review Chemistry, Medicinal

Natural products as important tyrosine kinase inhibitors

Bo Yin et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection
Review Agriculture, Multidisciplinary

The Multifunctional Benefits of Naturally Occurring Delphinidin and Its Glycosides

Zhixi Chen et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)

Add to Collection
Article Multidisciplinary Sciences

The role of natural products in modern drug discovery

Joao R. Calixto

ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2019)

Add to Collection
Review Chemistry, Medicinal

Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors

Barbara Guerra et al.

PHARMACEUTICALS (2019)

Add to Collection
Article Oncology

Cancer prevention and screening: the next step in the era of precision medicine

Holli A. Loomans-Kropp et al.

NPJ PRECISION ONCOLOGY (2019)

Add to Collection
Article Biochemistry & Molecular Biology

Comprehensive Characterization of Cancer Driver Genes and Mutations

Matthew H. Bailey et al.

CELL (2018)

Add to Collection
Article Oncology

Precision Prevention and Early Detection of Cancer: Fundamental Principles

Timothy R. Rebbeck et al.

CANCER DISCOVERY (2018)

Add to Collection
Article Endocrinology & Metabolism

Considerations for best practices in studies of fiber or other dietary components and the intestinal microbiome

David M. Klurfeld et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)

Add to Collection
Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection
Review Oncology

A comprehensive review of protein kinase inhibitors for cancer therapy

Radhamani Kannaiyan et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2018)

Add to Collection
Article Oncology

AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health

Scott M. Lippman et al.

CANCER PREVENTION RESEARCH (2018)

Add to Collection
Article Medicine, General & Internal

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer

D. P. Carbone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection
Review Food Science & Technology

Kaempferol - A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements

Dharambir Kashyap et al.

JOURNAL OF FUNCTIONAL FOODS (2017)

Add to Collection
Article Pharmacology & Pharmacy

Development of Certain Protein Kinase Inhibitors with the Components from Traditional Chinese Medicine

Minghua Liu et al.

FRONTIERS IN PHARMACOLOGY (2017)

Add to Collection
Review Immunology

Coinhibitory Pathways in Immunotherapy for Cancer

Susanne H. Baumeister et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)

Add to Collection
Review Pharmacology & Pharmacy

Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes

Robert Roskoski

PHARMACOLOGICAL RESEARCH (2016)

Add to Collection
Article Multidisciplinary Sciences

Evaluating the evaluation of cancer driver genes

Collin J. Tokheim et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Add to Collection
Article Oncology

The kinome 'at large' in cancer

Emmy D. G. Fleuren et al.

NATURE REVIEWS CANCER (2016)

Add to Collection
Review Pharmacology & Pharmacy

Ten things you should know about protein kinases: IUPHAR Review 14

Doriano Fabbro et al.

BRITISH JOURNAL OF PHARMACOLOGY (2015)

Add to Collection
Article Oncology

The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review)

Xiangjian Luo et al.

ONCOLOGY REPORTS (2015)

Add to Collection
Review Pharmacology & Pharmacy

A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets

Joost C. M. Uitdehaag et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

Add to Collection
Review Biochemistry & Molecular Biology

Natural products as kinase inhibitors

Jing Liu et al.

NATURAL PRODUCT REPORTS (2012)

Add to Collection
Editorial Material Chemistry, Medicinal

Pharmacognosy in modern pharmacy curricula

Satyajit D. Sarker

PHARMACOGNOSY MAGAZINE (2012)

Add to Collection
Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

CELL (2011)

Add to Collection
Review Pharmacology & Pharmacy

Reverse Pharmacognosy: Another Way to Harness the Generosity of Nature

S. Blondeau et al.

CURRENT PHARMACEUTICAL DESIGN (2010)

Add to Collection
Review Biochemistry & Molecular Biology

Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective

M Wink

PHYTOCHEMISTRY (2003)

Add to Collection
Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.

CELL (2000)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.